Funding for this research was provided by:
U.S. National Institutes of Health (1UM1HL134590)
Bill and Melinda Gates Foundation (OPP1131279)
National Heart, Lung, and Blood Institute (1F32HL143909-01, K12HL137942)
Fogarty International Center (D43TW009340)
Received: 22 October 2020
Accepted: 17 February 2021
First Online: 12 April 2021
: This project is a component of a larger clinical trial. The overall study protocol was reviewed and approved by institutional review boards (IRBs) or Ethics Committees at Emory University (00089799), Johns Hopkins University (00007403), Sri Ramachandra Institute of Higher Education and Research (IEC-N1/16/JUL/54/49) and the Indian Council of Medical Research – Health Ministry Screening Committee (5/8/4–30/(Env)/Indo-US/2016-NCD-I), Universidad del Valle de Guatemala (146–08-2016/11–2016) and Guatemalan Ministry of Health National Ethics Committee (11–2016), A.B. PRISMA (CE29841.17), the London School of Hygiene and Tropical Medicine (11664–5) and the Rwandan National Ethics Committee (No.357/RNEC/2018), and Washington University in St. Louis (201611159). Written consent was obtained from all participants.
: Not applicable.
: No authors have competing interests.